Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rockville, Maryland
- Most recent report
- 10-Q, filed Aug 11, 2026
- Incorporated
- Nevada
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 894158
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 97
News 8 of 362
Prospectuses and Registrations 8 of 110
- S-8 Registration statement for an employee plan Aug 24, 2026
- 424B5 Prospectus supplement for an offering Dec 3, 2025
- S-3 Shelf registration statement Nov 7, 2025
- 424B5 Prospectus supplement for an offering Oct 29, 2025
- 424B5 Prospectus supplement for an offering Oct 24, 2025
- 424B5 Prospectus supplement for an offering Oct 16, 2025
- 424B5 Prospectus supplement for an offering Oct 16, 2025
- 424B5 Prospectus supplement for an offering Oct 16, 2025
Proxies 8 of 68
- DEF 14A Proxy statement for a shareholder vote Jun 29, 2026
- PRE 14A Preliminary proxy statement Jun 18, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- PRE 14A Preliminary proxy statement Apr 20, 2026
- DEF 14A Proxy statement for a shareholder vote Mar 16, 2026
- PRE 14A Preliminary proxy statement Mar 4, 2026
- DEF 14A Proxy statement for a shareholder vote Jan 5, 2026
- PRE 14A Preliminary proxy statement Dec 23, 2025
Ownership 8 of 230
- 4 Insider reported a trade Jan 6, 2026
- 4 Insider reported a trade Jan 6, 2026
- 4 Insider reported a trade Jan 6, 2026
- 4 Insider reported a trade Jan 6, 2026
- SCHEDULE 13G Large holder reported a passive stake Nov 10, 2025
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 21, 2025
- SCHEDULE 13G Large holder reported a passive stake Jul 31, 2025
- 4 Insider reported a trade May 1, 2025
Other 8 of 133
- ARS Annual report sent to shareholders Jun 29, 2026
- EFFECT Notice that a registration became effective Dec 2, 2025
- CORRESP Reply to SEC staff Dec 1, 2025
- D Oct 24, 2025
- ARS Annual report sent to shareholders Jul 9, 2025
- EFFECT Notice that a registration became effective May 7, 2025
- CORRESP Reply to SEC staff May 5, 2025
- CORRESP Reply to SEC staff May 5, 2025
Everything here comes from Theriva Biologics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.